IE00BDZVHG35
IE00BDZVHG35
iShares Nasdaq US Biotechnology UCITS ETF
Loading chart...
About this ETF
The iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) seeks to track the Nasdaq Biotechnology index. The Nasdaq Biotechnology index tracks Nasdaq listed companies primarily engaged in biomedical research to develop new treatments and cures for human disease.
TER
0.35%
Total Expense Ratio per year
Fund Size
€1.1B
Assets under management
Holdings
250
Underlying equities
Dividend Yield
0.21%
Distributing
Fundamentals & Estimates
Weighted valuation multiples and analyst forecasts
Valuation Multiples
Weighted P/E
17.86
Weighted Fwd P/E
69.59
💰 Revenue Estimates
Current Year CY
+34.09% ⌀ 18 Analysts Coverage
Next Year NY
+397.78% ⌀ 18 Analysts Coverage
📈 EPS Estimates (Earnings Per Share)
Current Year CY
-305.41% ⌀ 16 Analysts Coverage
Next Year NY
+219.85% ⌀ 15 Analysts Coverage
Related ETFs
State Street® SPDR® S&P® U.S. Health Care Select Sector UCITS ETF (Acc)
53.06 USD
TER 0.15% 1Y +17.3%
Invesco Health Care S&P US Select Sector UCITS ETF Acc
846.5 USD
TER 0.14% 1Y +17.4%
ETF Profile
Provider
Fund Type
ETF Type
Passive Inception Date
03/05/2018 (8 yrs)
Index Group
NASDAQ Biotechnology Index
Nasdaq Biotechnology Region
-
Country
United States Sector
Health Care Strategy
-
Theme
Biotech Distribution Policy
Distributing Replication
Optimized sampling Sustainable
No 🛡️ Risk & Structural Analysis
Multi-Factor Risk Model & Market Data
6/7 High
Diversification Score: 16/100 Low (Concentration Risk)
Diversification Score
16/100 Low (Concentration Risk)
5Y Volatility
21.1% p.a.
Max Drawdown (5Y)
-34.8%
Sharpe Ratio (5Y)
0.23
Beta Factor
0.82
Notes & Warnings
Fund Volume (AUM) 🟢 Established large fund (> 500M € AUM)
🟡 Moderate analyst coverage (16 analysts)
🔴 Severe sector concentration risk: 100% in "Healthcare".
🔴 Extreme industry concentration: 68% in "Biotechnology".
⚠️ Elevated Regulatory & Policy Risk: 100% in heavily regulated industries (defense, regulated utilities, healthcare policy).